$4.01
+0.01 (+0.25%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+806.0% upside
Low Target
$21.56
Average Target
$36.33
High Target
$42.60
Current Price
$4.01
Current
$4.01
$4.01
Target
$36.33
$36.33
$21.56
$36.33 avg
$42.60
Scenario Analysis
Bear Case
$21.56
437.7%
Low target
Base Case
$36.33
+806.0%
Avg target
Bull Case
$42.60
+962.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$20.00
-80.0% from high
52-Week Low
$3.29
+21.9% from low
Target vs 52W High
$36.33
+81.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |